Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive deficits. Group therapy may be a new, promising intervention.

Schizophrenia is the classic psychotic disorder and has long been considered the most severe form of mental illness. It is a problem that afflicts roughly 1 out of 100 people around the world. Since ...

CINCINNATI, Ohio. (Ivanhoe Newswire) - Schizophrenia, the statistics are terrifying. More than 3.7 million people are living with it right now in the United States. If left untreated it can be ...

For individuals diagnosed with schizophrenia, maintaining a daily medication routine can feel like an insurmountable challenge. The cognitive impairments associated with the disorder often interfere ...

On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. Bristol-Myers added the ...

Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized psychosis treatment.

Schizoaffective disorder and schizophrenia are separate mental disorders. Learn about both, including symptoms, risk factors, and treatment.

A commonly prescribed antibiotic used to treat skin conditions and infections may offer protection against the development of ...

Neurocrine Biosciences Inc. plunged early Wednesday after a study of its experimental schizophrenia treatment was disappointing when compared to a rival medicine that’s likely to hit the market much ...

Many people live with a secret that feels almost impossible to describe. They hear speech or whispers that nobody else ...